NEW YORK (GenomeWeb) — Definiens said today that it has entered a biomarker alliance with Germany's Merck KGaA.

Under the terms of the multi-year deal, Merck's healthcare business will use Definiens' web-based collaboration software platform — which enables the uploading, accessing, searching, and sharing of data — to support its use of Definiens' Tissue Phenomics image-analysis technologies for biomarker quantification including immuno-profiling.

Additional terms were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.